MiNK Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
MiNK Therapeutics, Inc. has filed 263 SEC EDGAR filings since 22 Jan 2021

SEC filing history

Showing 76-100 of 263 matching filings.

Per page
25
Current page
4
ARS File 001-40908

ARS

Filing date
30 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40908

DEF 14A

Filing date
30 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40908

PRE 14A

Filing date
18 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Mar 2025
Reporting date
03 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Mar 2025
Reporting date
03 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Mar 2025
Reporting date
03 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Mar 2025
Reporting date
03 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Mar 2025
Reporting date
03 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40908

DEF14A

Filing date
20 Dec 2024
Reporting date
17 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Dec 2024
Reporting date
30 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
09 Dec 2024
Reporting date
30 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40908

PRE14A

Filing date
06 Dec 2024
Reporting date
17 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Dec 2024
Reporting date
01 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Dec 2024
Reporting date
01 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Dec 2024
Reporting date
01 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Dec 2024
Reporting date
01 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .